Europe Cancer Spit Test Device Market – Industry Trends and Forecast to 2028

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Europe Cancer Spit Test Device Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Published Report
  • Aug 2021
  • Europe
  • 350 Pages
  • No of Tables: 159
  • No of Figures: 49

Europe Cancer Spit Test Device Market, By Product Type (Saliva Collection Kits, Fluid Specific Devices, Oral Swab, Bar-Code Labels, Saliva Cryostorage Box and Others), Site Of Collection (Sub-Mandibular/Sub-Lingual Gland, Parotid Gland and Minor Salivary Gland), Application (Liver-Lung Cancer, Breast Cancer, Colon And Rectal Cancer, Prostate Cancer, Pancreatic Cancer, Oral Cancer, Thyroid Cancer, Endometrial Cancer, Kidney Cancer, Leukemia, Melanoma, Non-Hodgkin Lymphoma, and Others), Age Group (Adult and Pediatrics), Method Of Collection (Passive Drool, Oral Swab and Others), End User (Hospitals, Diagnostic Laboratories, Oncology Speciality Clinics, Cancer Research Institutes, and Others), Distribution Channel (Direct Tenders, Retail Sales, and Others) Country (Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Austria, Sweden, Belgium, Estonia, and Rest of Europe) Industry Trends and Forecast to 2028.

Europe Cancer Spit Test Device Market Market Analysis and Insights: Europe Cancer Spit Test Device Market

Europe cancer spit test device market is expected to gain significant growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyzes that the Europe cancer spit test device market is growing with a CAGR of 9.3% in the forecast period of 2021 to 2028 and is expected to reach USD 224.29 million by 2028 from USD 115.22 million in 2020. Rising prevalence of chronic diseases and increasing number of cancer patients are the major drivers, which are expected to propel the growth of the market in the forecast period.

A saliva test is nowadays extensively used for cancer detection. A cancer saliva would test for the presence or absence of mutated extra-cellular DNA and RNA. The tumor cells shed DNA and RNA into the circulation and they come into saliva, and mutations are detectable with great accuracy in saliva.

The cancer saliva test devices market comprises testing kits, swabs, cassettes, and devices used for the detection of drugs, infections, or diseases in human beings. Several types of kits utilize different types of molecular biology methods for disease detection. ELISA, PCR, immunoassay, and enzymatic assays among others are molecular techniques that are used for saliva testing.

The Europe cancer spit test device market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.   

Europe Cancer Spit Test Device Market The Europe Cancer Spit Test Device Market Scope and Market Size

The Europe cancer spit test device market is segmented on the basis of product type, site of collection, application, age group, method of collection, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product type, the Europe cancer spit test devices market is segmented into saliva collection kits, fluid specific devices, oral swab, bar-code labels, saliva cryostorage box, and others.  In 2021, saliva collection kits segment is expected to dominate the market due to increasing pool of cancer patients in the region.
  • On the basis of site of collection, the Europe cancer spit test devices market is segmented into sub-mandibular/sub-lingual gland, parotid gland, and minor salivary gland. In 2021, sub-mandibular/sub-lingual gland segment is expected to dominate the market owing to increasing healthcare expenditure and growing awareness among people about cancer.
  • On the basis of application, the Europe cancer spit test devices market is segmented into liver-lung cancer, breast cancer, colon and rectal cancer, prostate cancer, pancreatic cancer, oral cancer, thyroid cancer, endometrial cancer, kidney cancer, leukemia, melanoma, non-hodgkin lymphoma, and others. In 2021, liver-lung cancer segment is expected to dominate the market owing to excessive smoking among people and rising prevalence of liver cirrhosis.
  • On the basis of age group, the Europe cancer spit test devices market is segmented into adult and pediatrics. In 2021, adult segment is expected to dominate the market owing to surging pool of geriatric population and increasing prevalence chronic diseases in the region.
  • On the basis of method of collection, the Europe cancer spit test devices market is segmented into passive drool, oral swab, and others. In 2021, passive drool segment is expected to dominate the market owing to its non-invasive method with better patient compliance.
  • On the basis of end user, the Europe cancer spit test devices market is segmented into hospitals, diagnostic laboratories, oncology specialty clinics, cancer research institutes, and others. In 2021, hospitals segment is expected to dominate the market owing to surging volume of cancer patients and better treatment options for different types of cancer.
  • On the basis of distribution channel, the Europe cancer spit test devices market is segmented into direct tender, retail sales, and others. In 2021, direct sales segment is expected to dominate the market owing to growing presence of major players in the market.

Europe Cancer Spit Test Devices Market Country Level Analysis

The Europe cancer spit test devices market is analyzed and market size information is provided based on product type, site of collection, application, age group, method of collection, end user, and distribution channel.

Countries covered in the Europe cancer spit test device market report are Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Austria, Sweden, Belgium, Estonia, and Rest of Europe. The market in Europe is expected to grow significantly in the forecast period of 2021 to 2028 due to increasing technological advancements in the region. Germany is dominating the European market owing to growing presence of key players in the market.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Rising Healthcare Expenditure and High Prevalence of Cancer are Creating New Opportunities for Players in the Europe cancer spit test devices market

Germany is leading the growth of Europe region and saliva collection kits segment is dominating the country due to rising demand for POCT devices.

Europe cancer spit test devices market also provides you with detailed market analysis for every country growth in particular industry with the Europe cancer spit test device market sales, impact of advancement in the Europe cancer spit test device market and changes in regulatory scenarios with their support for the Europe cancer spit test devices market. The data is available for historic period 2010 to 2018. 

Competitive Landscape and Europe Cancer Spit Test Device Market Share Analysis

Europe cancer spit test device market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, and technology lifeline curve. The above data points provided are only related to the companies’ focus related to Europe cancer spit test devices market.

Major players covered in the report are DNA Genotek, Salimetrics, LLC, PeriRx, Color Health, Inc., SARSTEDT AG. Co. KG,  Miraclean Technology Co., Ltd.,  Agilent Technologies, Inc., Illumina, Inc., QIAGEN, Thermo Fisher Scientific Inc., Abbott, BD, Biocartis, bioMérieux SA, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd,  Oasis Diagnostics Corporation, and Canvax ( a subsidiary of dobuss) among other domestic and Europe players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launches and agreements are also initiated by the companies worldwide, which are further accelerating the growth of the Europe cancer spit test device market.

For instance,

  • In February 2021, Thermo Fisher Scientific was recognized with six CMO Leadership Awards. It won across all six categories, including capabilities, compatibility, expertise, quality, reliability, and service. This is the second consecutive year Thermo Fisher has received this recognition across all six categories and the eighth time overall that the company has been honored by the CMO Leadership Awards. This has increased the credibility of the company and aided in revenue generation.
  • In January 2021, DNA Genotek announced that the U.S. Food and Drug Administration (FDA) has granted a general use 510(k) clearance for its OrageneDx family of products. This FDA approval has increased the credibility of the company in the market and increased the demand for this product.


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF EUROPE CANCER SPIT TEST DEVICES MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 REGULATORY FRAMEWORKS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 RISE IN CANCER BURDEN WORLDWIDE

6.1.2 INCREASE IN INITIATIVES BY GOVERNMENT AND OTHER HEALTHCARE ORGANIZATIONS

6.1.3 RISE IN GERIATRIC POPULATION

6.1.4 RISE IN PRODUCT APPROVALS AND LAUNCHES FOR CANCER

6.1.5 RISE IN EXPENDITURE ON HEALTHCARE

6.2 RESTRAINTS

6.2.1 INCREASE PREVALENCE OF COVID-19

6.2.2 LACK OF EARLY DETECTION

6.3 OPPORTUNITIES

6.3.1 RECOMMENDATIONS FOR CANCER SCREENING

6.3.2 RISE IN DEMAND OF POINT-OF-CARE TESTING

6.3.3 RISE IN R&D ACTIVITIES

6.4 CHALLENGES

6.4.1 STRINGENT REGULATION POLICY

6.4.2 RISING COMPETITION AMONG MARKET PLAYERS

7 IMPACT OF COVID-19 THE ON EUROPE CANCER SPIT TEST DEVICES MARKET

7.1 IMPACT ON SUPPLY CHAIN

7.2 IMPACT ON DEMAND

7.3 STRATEGIC DECISIONS FOR MANUFACTURERS

7.4 CONCLUSION

8 EUROPE CANCER SPIT TEST DEVICE MARKET, BY PRODUCT TYPE

8.1 OVERVIEW

8.2 SALIVA COLLECTION KIT

8.2.1 DNA EXTRACT

8.2.2 RNA EXTRACT

8.3 FLUID SPECIFIC DEVICES

8.4 ORAL SWAB

8.5 BAR-CODE LABELS

8.6 SALIVA CRYOSTORAGE BOX

8.7 OTHERS

9 EUROPE CANCER SPIT TEST DEVICE MARKET, BY SITE OF COLLECTION

9.1 OVERVIEW

9.2 SUB-MANDIBULAR/SUB-LINGUAL GLAND

9.3 PAROTID GLAND

9.4 MINOR SALIVARY GLAND

10 EUROPE CANCER SPIT TEST DEVICE MARKET, BY APPLICATION

10.1 OVERVIEW

10.2 LIVER-LUNG CANCER

10.3 BREAST CANCER

10.4 COLON AND RECTAL CANCER

10.5 PROSTATE CANCER

10.6 PANCREATIC CANCER

10.7 ORAL CANCER

10.8 THYROID CANCER

10.9 ENDOMETRIAL CANCER

10.1 KIDNEY CANCER

10.11 LEUKEMIA

10.12 MELANOMA

10.13 NON-HODGKIN LYMPHOMA

10.14 OTHERS

11 EUROPE CANCER SPIT TEST DEVICE MARKET, BY AGE GROUP

11.1 OVERVIEW

11.2 ADULT

11.3 PEDIATRICS

12 EUROPE CANCER SPIT TEST DEVICE MARKET, BY METHOD OF COLLECTION

12.1 OVERVIEW

12.2 PASSIVE DROOL

12.3 ORAL SWAB

12.4 OTHERS

13 EUROPE CANCER SPIT TEST DEVICE MARKET, BY END USER

13.1 OVERVIEW

13.2 HOSPITALS

13.3 DIAGNOSTIC LABORATORIES

13.4 ONCOLOGY SPECIALITY CLINICS

13.5 CANCER RESEARCH INSTITUTES

13.6 OTHERS

14 EUROPE CANCER SPIT TEST DEVICE MARKET, BY DISTRIBUTION CHANNEL

14.1 OVERVIEW

14.2 DIRECT TENDER

14.3 RETAIL SALES

14.4 OTHERS

15 EUROPE CANCER SPIT TEST DEVICES MARKET, BY REGION

15.1 EUROPE

15.1.1 GERMANY

15.1.2 FRANCE

15.1.3 U.K.

15.1.4 ITALY

15.1.5 SPAIN

15.1.6 BELGIUM

15.1.7 NETHERLANDS

15.1.8 SWITZERLAND

15.1.9 AUSTRIA

15.1.10 RUSSIA

15.1.11 SWEDEN

15.1.12 TURKEY

15.1.13 ESTONIA

15.1.14 REST OF EUROPE

16 EUROPE CANCER SPIT TEST DEVICES MARKET: COMPANY LANDSCAPE

16.1 COMPANY SHARE ANALYSIS: EUROPE

17 SWOT ANALYSIS

18 COMPANY PROFILE

18.1 BIOCARTIS

18.1.1 COMPANY SNAPSHOT

18.1.2 REVENUE ANALYSIS

18.1.3 COMPANY SHARE ANALYSIS

18.1.4 PRODUCT PORTFOLIO

18.1.5 RECENT DEVELOPMENTS

18.2 BD

18.2.1 COMPANY SNAPSHOT

18.2.2 COMPANY SHARE ANALYSIS

18.2.3 PRODUCT PORTFOLIO

18.2.4 RECENT DEVELOPMENT

18.3 ABBOTT

18.3.1 COMPANY SNAPSHOT

18.3.2 REVENUE ANALYSIS

18.3.3 COMPANY SHARE ANALYSIS

18.3.4 PRODUCT PORTFOLIO

18.3.5 RECENT DEVELOPMENT

18.4 F. HOFFMANN-LA ROCHE LTD

18.4.1 COMPANY SNAPSHOT

18.4.2 REVENUE ANALYSIS

18.4.3 COMPANY SHARE ANALYSIS

18.4.4 PRODUCT PORTFOLIO

18.4.5 RECENT DEVELOPMENT

18.5 QIAGEN

18.5.1 COMPANY SNAPSHOT

18.5.2 REVENUE ANALYSIS

18.5.3 COMPANY SHARE ANALYSIS

18.5.4 PRODUCT PORTFOLIO

18.5.5 RECENT DEVELOPMENTS

18.6 AGILENT TECHNOLOGIES, INC.

18.6.1 COMPANY SNAPSHOT

18.6.2 REVENUE ANALYSIS

18.6.3 PRODUCT PORTFOLIO

18.6.4 RECENT DEVELOPMENTS

18.7 BIOMÉRIEUX SA

18.7.1 COMPANY SNAPSHOT

18.7.2 REVENUE ANALYSIS

18.7.3 PRODUCT PORTFOLIO

18.7.4 RECENT DEVELOPMENT

18.8 CANVAX

18.8.1 COMPANY SNAPSHOT

18.8.2 PRODUCT PORTFOLIO

18.8.3 RECENT DEVELOPMENT

18.9 COLOR HEALTH, INC.

18.9.1 1.6.1 COMPANY SNAPSHOT

18.9.2 1.6.2 PRODUCT PORTFOLIO

18.9.3 RECENT DEVELOPMENT

18.1 DNA GENOTEK

18.10.1 COMPANY SNAPSHOT

18.10.2 REVENUE ANALYSIS

18.10.3 PRODUCT PORTFOLIO

18.10.4 RECENT DEVELOPMENT

18.11 ILLUMINA, INC.

18.11.1 COMPANY SNAPSHOT

18.11.2 REVENUE ANALYSIS

18.11.3 PRODUCT PORTFOLIO

18.11.4 RECENT DEVELOPMENTS

18.12 MIRACLEAN TECHNOLOGY CO.,LTD.

18.12.1 COMPANY SNAPSHOT

18.12.2 PRODUCT PORTFOLIO

18.12.3 RECENT DEVELOPMENT

18.13 OASIS DIAGNOSTICS CORPORATION

18.13.1 COMPANY SNAPSHOT

18.13.2 PRODUCT PORTFOLIO

18.13.3 RECENT DEVELOPMENT

18.14 PERIRX

18.14.1 COMPANY SNAPSHOT

18.14.2.2 PRODUCT PORTFOLIO

18.14.3 RECENT DEVELOPMENT

18.15 SALIMETRICS, LLC

18.15.1 COMPANY SNAPSHOT

18.15.2 PRODUCT PORTFOLIO

18.15.3 RECENT DEVELOPMENT

18.16 SARSTEDT AG & CO. KG

18.16.1 COMPANY SNAPSHOT

18.16.2 PRODUCT PORTFOLIO

18.16.3 RECENT DEVELOPMENT

18.17 SIEMENS HEALTHCARE S.A.E. (A SUBSIDIARY OF SIEMENS HEALTHINEERS AG)

18.17.1 COMPANY SNAPSHOT

18.17.2 REVENUE ANALYSIS

18.17.3 PRODUCT PORTFOLIO

18.17.4 RECENT DEVELOPMENTS

18.18 THERMO FISHER SCIENTIFIC INC.

18.18.1 COMPANY SNAPSHOT

18.18.2 REVENUE ANALYSIS

18.18.3 PRODUCT PORTFOLIO

18.18.4 RECENT DEVELOPMENT

19 QUESTIONNAIRE

20 RELATED REPORTS

List of Table

LIST OF TABLES 

TABLE 1 NEW CANCER CASES, AGES 85+, IN THE U.S.

TABLE 2 DEATH CAUSES DUE TO CANCER, AGES 85+, IN THE U.S.

TABLE 3 EUROPE CANCER SPIT TEST DEVICE MARKET, By product Type, 2019-2028 (USD million)

TABLE 4 EUROPE saliva collection kit IN CANCER SPIT TEST DEVICE MARKET, By Region, 2019-2028 (USD Million)

TABLE 5 Europe Saliva Collection Kit in Cancer Spit Test Devices Market, By Product Type, 2019-2028 (USD Million)

TABLE 6 Europe Fluid Specific Devices in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)

TABLE 7 Europe Oral Swab in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)

TABLE 8 Europe Bar-Code Labels in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)

TABLE 9 Europe Saliva Cryostorage Box in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)

TABLE 10 Europe Others in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)

TABLE 11 EUROPE CANCER SPIT TEST DEVICE MARKET, By SITE OF COLLECTION, 2019-2028 (USD Million)

TABLE 12 Europe Sub-mandibular/Sub-lingual GLAND in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)

TABLE 13 Europe Parotid Gland in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)

TABLE 14 Europe Minor Salivary Gland in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)

TABLE 15 Europe Cancer Spit Test Devices Market, By Application, 2019-2028 (USD Million)

TABLE 16 Europe Liver-Lung Cancer in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)

TABLE 17 Europe Breast Cancer in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)

TABLE 18 Europe Colon and Rectal Cancer in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)

TABLE 19 Europe Prostate Cancer in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)

TABLE 20 Europe Pancreatic Cancer in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)

TABLE 21 Europe Oral Cancer in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)

TABLE 22 Europe Thyroid Cancer in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)

TABLE 23 Europe Endometrial Cancer in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)

TABLE 24 Europe Kidney Cancer in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)

TABLE 25 Europe Leukemia in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)

TABLE 26 Europe Melanoma in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)

TABLE 27 Europe Non-Hodgkin Lymphoma in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)

TABLE 28 Europe Others in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)

TABLE 29 EUROPE CANCER SPIT TEST DEVICE MARKET, By AGE GROUP, 2019-2028 (USD million)

TABLE 30 Europe Adult in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)

TABLE 31 Europe Pediatrics in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)

TABLE 32 Europe Cancer Spit Test Devices Market, By Method of Collection, 2019-2028 (USD Million)

TABLE 33 Europe Passive Drool in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)

TABLE 34 Europe Oral Swab in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)

TABLE 35 Europe Others in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)

TABLE 36 Europe Cancer Spit Test Devices Market, By END USER, 2019-2028 (USD Million)

TABLE 37 Europe Hospitals in Cancer Spit Test Devices Market, By region, 2019-2028 (USD Million)

TABLE 38 Europe Diagnostic Laboratories in Cancer Spit Test Devices Market, By region, 2019-2028 (USD Million)

TABLE 39 Europe Oncology Speciality Clinics in Cancer Spit Test Devices Market, By region, 2019-2028 (USD Million)

TABLE 40 Europe Cancer Research Institutes in Cancer Spit Test Devices Market, By region, 2019-2028 (USD Million)

TABLE 41 Europe Others in Cancer Spit Test Devices Market, By region, 2019-2028 (USD Million)

TABLE 42 Europe Cancer Spit Test Devices Market, By DISTRIBUTION CHANNEL, 2019-2028 (USD Million)

TABLE 43 Europe Direct Tender in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)

TABLE 44 Europe Retail Sales in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)

TABLE 45 Europe Others in Cancer Spit Test Devices Market, By Region, 2019-2028 (USD Million)

TABLE 46 EUROPE CANCER SPIT TEST DEVICES market, By Country, 2019-2028 (USD Million)

TABLE 47 EUROPE CANCER SPIT TEST DEVICES MARKET, By Product TYPE, 2019-2028 (USD Million)

TABLE 48 EUROPE Saliva Collection Kit in CANCER SPIT TEST DEVICES MARKET, By Product Type, 2019-2028 (USD Million)

TABLE 49 EUROPE CANCER SPIT TEST DEVICES MARKET, By Site of Collection, 2019-2028 (USD Million)

TABLE 50 EUROPE CANCER SPIT TEST DEVICES MARKET, By Application, 2019-2028 (USD Million)

TABLE 51 EUROPE CANCER SPIT TEST DEVICES MARKET, By Age Group, 2019-2028 (USD Million)

TABLE 52 EUROPE CANCER SPIT TEST DEVICES MARKET, By Method of Collection, 2019-2028 (USD Million)

TABLE 53 EUROPE CANCER SPIT TEST DEVICES MARKET, By End User, 2019-2028 (USD Million)

TABLE 54 EUROPE CANCER SPIT TEST DEVICES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 55 GERMANY CANCER SPIT TEST DEVICES MARKET, By Product TYPE, 2019-2028 (USD Million)

TABLE 56 GERMANY Saliva Collection Kit in CANCER SPIT TEST DEVICES MARKET, By Product Type, 2019-2028 (USD Million)

TABLE 57 GERMANY CANCER SPIT TEST DEVICES MARKET, By Site of Collection, 2019-2028 (USD Million)

TABLE 58 GERMANY CANCER SPIT TEST DEVICES MARKET, By Application, 2019-2028 (USD Million)

TABLE 59 GERMANY CANCER SPIT TEST DEVICES MARKET, By Age Group, 2019-2028 (USD Million)

TABLE 60 GERMANY CANCER SPIT TEST DEVICES MARKET, By Method of Collection, 2019-2028 (USD Million)

TABLE 61 GERMANY CANCER SPIT TEST DEVICES MARKET, By End User, 2019-2028 (USD Million)

TABLE 62 GERMANY CANCER SPIT TEST DEVICES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 63 FRANCE CANCER SPIT TEST DEVICES MARKET, By Product TYPE, 2019-2028 (USD Million)

TABLE 64 FRANCE Saliva Collection Kit in CANCER SPIT TEST DEVICES MARKET, By Product Type, 2019-2028 (USD Million)

TABLE 65 FRANCE CANCER SPIT TEST DEVICES MARKET, By Site of Collection, 2019-2028 (USD Million)

TABLE 66 FRANCE CANCER SPIT TEST DEVICES MARKET, By Application, 2019-2028 (USD Million)

TABLE 67 FRANCE CANCER SPIT TEST DEVICES MARKET, By Age Group, 2019-2028 (USD Million)

TABLE 68 FRANCE CANCER SPIT TEST DEVICES MARKET, By Method of Collection, 2019-2028 (USD Million)

TABLE 69 FRANCE CANCER SPIT TEST DEVICES MARKET, By End User, 2019-2028 (USD Million)

TABLE 70 FRANCE CANCER SPIT TEST DEVICES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 71 U.K. CANCER SPIT TEST DEVICES MARKET, By Product TYPE, 2019-2028 (USD Million)

TABLE 72 U.K. Saliva Collection Kit in CANCER SPIT TEST DEVICES MARKET, By Product Type, 2019-2028 (USD Million)

TABLE 73 U.K. CANCER SPIT TEST DEVICES MARKET, By Site of Collection, 2019-2028 (USD Million)

TABLE 74 U.K. CANCER SPIT TEST DEVICES MARKET, By Application, 2019-2028 (USD Million)

TABLE 75 U.K. CANCER SPIT TEST DEVICES MARKET, By Age Group, 2019-2028 (USD Million)

TABLE 76 U.K. CANCER SPIT TEST DEVICES MARKET, By Method of Collection, 2019-2028 (USD Million)

TABLE 77 U.K. CANCER SPIT TEST DEVICES MARKET, By End User, 2019-2028 (USD Million)

TABLE 78 U.K. CANCER SPIT TEST DEVICES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 79 ITALY CANCER SPIT TEST DEVICES MARKET, By Product TYPE, 2019-2028 (USD Million)

TABLE 80 ITALY Saliva Collection Kit in CANCER SPIT TEST DEVICES MARKET, By Product Type, 2019-2028 (USD Million)

TABLE 81 ITALY CANCER SPIT TEST DEVICES MARKET, By Site of Collection, 2019-2028 (USD Million)

TABLE 82 ITALY CANCER SPIT TEST DEVICES MARKET, By Application, 2019-2028 (USD Million)

TABLE 83 ITALY CANCER SPIT TEST DEVICES MARKET, By Age Group, 2019-2028 (USD Million)

TABLE 84 ITALY CANCER SPIT TEST DEVICES MARKET, By Method of Collection, 2019-2028 (USD Million)

TABLE 85 ITALY CANCER SPIT TEST DEVICES MARKET, By End User, 2019-2028 (USD Million)

TABLE 86 ITALY CANCER SPIT TEST DEVICES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 87 SPAIN CANCER SPIT TEST DEVICES MARKET, By Product TYPE, 2019-2028 (USD Million)

TABLE 88 SPAIN Saliva Collection Kit in CANCER SPIT TEST DEVICES MARKET, By Product Type, 2019-2028 (USD Million)

TABLE 89 SPAIN CANCER SPIT TEST DEVICES MARKET, By Site of Collection, 2019-2028 (USD Million)

TABLE 90 SPAIN CANCER SPIT TEST DEVICES MARKET, By Application, 2019-2028 (USD Million)

TABLE 91 SPAIN CANCER SPIT TEST DEVICES MARKET, By Age Group, 2019-2028 (USD Million)

TABLE 92 SPAIN CANCER SPIT TEST DEVICES MARKET, By Method of Collection, 2019-2028 (USD Million)

TABLE 93 SPAIN CANCER SPIT TEST DEVICES MARKET, By End User, 2019-2028 (USD Million)

TABLE 94 SPAIN CANCER SPIT TEST DEVICES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 95 BELGIUM CANCER SPIT TEST DEVICES MARKET, By Product TYPE, 2019-2028 (USD Million)

TABLE 96 BELGIUM Saliva Collection Kit in CANCER SPIT TEST DEVICES MARKET, By Product Type, 2019-2028 (USD Million)

TABLE 97 BELGIUM CANCER SPIT TEST DEVICES MARKET, By Site of Collection, 2019-2028 (USD Million)

TABLE 98 BELGIUM CANCER SPIT TEST DEVICES MARKET, By Application, 2019-2028 (USD Million)

TABLE 99 BELGIUM CANCER SPIT TEST DEVICES MARKET, By Age Group, 2019-2028 (USD Million)

TABLE 100 BELGIUM CANCER SPIT TEST DEVICES MARKET, By Method of Collection, 2019-2028 (USD Million)

TABLE 101 BELGIUM CANCER SPIT TEST DEVICES MARKET, By End User, 2019-2028 (USD Million)

TABLE 102 BELGIUM CANCER SPIT TEST DEVICES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 103 NETHERLANDS CANCER SPIT TEST DEVICES MARKET, By Product TYPE, 2019-2028 (USD Million)

TABLE 104 NETHERLANDS Saliva Collection Kit in CANCER SPIT TEST DEVICES MARKET, By Product Type, 2019-2028 (USD Million)

TABLE 105 NETHERLANDS CANCER SPIT TEST DEVICES MARKET, By Site of Collection, 2019-2028 (USD Million)

TABLE 106 NETHERLANDS CANCER SPIT TEST DEVICES MARKET, By Application, 2019-2028 (USD Million)

TABLE 107 NETHERLANDS CANCER SPIT TEST DEVICES MARKET, By Age Group, 2019-2028 (USD Million)

TABLE 108 NETHERLANDS CANCER SPIT TEST DEVICES MARKET, By Method of Collection, 2019-2028 (USD Million)

TABLE 109 NETHERLANDS CANCER SPIT TEST DEVICES MARKET, By End User, 2019-2028 (USD Million)

TABLE 110 NETHERLANDS CANCER SPIT TEST DEVICES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 111 SWITZERLAND CANCER SPIT TEST DEVICES MARKET, By Product TYPE, 2019-2028 (USD Million)

TABLE 112 SWITZERLAND Saliva Collection Kit in CANCER SPIT TEST DEVICES MARKET, By Product Type, 2019-2028 (USD Million)

TABLE 113 SWITZERLAND CANCER SPIT TEST DEVICES MARKET, By Site of Collection, 2019-2028 (USD Million)

TABLE 114 SWITZERLAND CANCER SPIT TEST DEVICES MARKET, By Application, 2019-2028 (USD Million)

TABLE 115 SWITZERLAND CANCER SPIT TEST DEVICES MARKET, By Age Group, 2019-2028 (USD Million)

TABLE 116 SWITZERLAND CANCER SPIT TEST DEVICES MARKET, By Method of Collection, 2019-2028 (USD Million)

TABLE 117 SWITZERLAND CANCER SPIT TEST DEVICES MARKET, By End User, 2019-2028 (USD Million)

TABLE 118 SWITZERLAND CANCER SPIT TEST DEVICES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 119 AUSTRIA CANCER SPIT TEST DEVICES MARKET, By Product TYPE, 2019-2028 (USD Million)

TABLE 120 AUSTRIA Saliva Collection Kit in CANCER SPIT TEST DEVICES MARKET, By Product Type, 2019-2028 (USD Million)

TABLE 121 AUSTRIA CANCER SPIT TEST DEVICES MARKET, By Site of Collection, 2019-2028 (USD Million)

TABLE 122 AUSTRIA CANCER SPIT TEST DEVICES MARKET, By Application, 2019-2028 (USD Million)

TABLE 123 AUSTRIA CANCER SPIT TEST DEVICES MARKET, By Age Group, 2019-2028 (USD Million)

TABLE 124 AUSTRIA CANCER SPIT TEST DEVICES MARKET, By Method of Collection, 2019-2028 (USD Million)

TABLE 125 AUSTRIA CANCER SPIT TEST DEVICES MARKET, By End User, 2019-2028 (USD Million)

TABLE 126 AUSTRIA CANCER SPIT TEST DEVICES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 127 RUSSIA CANCER SPIT TEST DEVICES MARKET, By Product TYPE, 2019-2028 (USD Million)

TABLE 128 RUSSIA Saliva Collection Kit in CANCER SPIT TEST DEVICES MARKET, By Product Type, 2019-2028 (USD Million)

TABLE 129 RUSSIA CANCER SPIT TEST DEVICES MARKET, By Site of Collection, 2019-2028 (USD Million)

TABLE 130 RUSSIA CANCER SPIT TEST DEVICES MARKET, By Application, 2019-2028 (USD Million)

TABLE 131 RUSSIA CANCER SPIT TEST DEVICES MARKET, By Age Group, 2019-2028 (USD Million)

TABLE 132 RUSSIA CANCER SPIT TEST DEVICES MARKET, By Method of Collection, 2019-2028 (USD Million)

TABLE 133 RUSSIA CANCER SPIT TEST DEVICES MARKET, By End User, 2019-2028 (USD Million)

TABLE 134 RUSSIA CANCER SPIT TEST DEVICES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 135 SWEDEN CANCER SPIT TEST DEVICES MARKET, By Product TYPE, 2019-2028 (USD Million)

TABLE 136 SWEDEN Saliva Collection Kit in CANCER SPIT TEST DEVICES MARKET, By Product Type, 2019-2028 (USD Million)

TABLE 137 SWEDEN CANCER SPIT TEST DEVICES MARKET, By Site of Collection, 2019-2028 (USD Million)

TABLE 138 SWEDEN CANCER SPIT TEST DEVICES MARKET, By Application, 2019-2028 (USD Million)

TABLE 139 SWEDEN CANCER SPIT TEST DEVICES MARKET, By Age Group, 2019-2028 (USD Million)

TABLE 140 SWEDEN CANCER SPIT TEST DEVICES MARKET, By Method of Collection, 2019-2028 (USD Million)

TABLE 141 SWEDEN CANCER SPIT TEST DEVICES MARKET, By End User, 2019-2028 (USD Million)

TABLE 142 SWEDEN CANCER SPIT TEST DEVICES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 143 TURKEY CANCER SPIT TEST DEVICES MARKET, By Product TYPE, 2019-2028 (USD Million)

TABLE 144 TURKEY Saliva Collection Kit in CANCER SPIT TEST DEVICES MARKET, By Product Type, 2019-2028 (USD Million)

TABLE 145 TURKEY CANCER SPIT TEST DEVICES MARKET, By Site of Collection, 2019-2028 (USD Million)

TABLE 146 TURKEY CANCER SPIT TEST DEVICES MARKET, By Application, 2019-2028 (USD Million)

TABLE 147 TURKEY CANCER SPIT TEST DEVICES MARKET, By Age Group, 2019-2028 (USD Million)

TABLE 148 TURKEY CANCER SPIT TEST DEVICES MARKET, By Method of Collection, 2019-2028 (USD Million)

TABLE 149 TURKEY CANCER SPIT TEST DEVICES MARKET, By End User, 2019-2028 (USD Million)

TABLE 150 TURKEY CANCER SPIT TEST DEVICES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 151 ESTONIA CANCER SPIT TEST DEVICES MARKET, By Product TYPE, 2019-2028 (USD Million)

TABLE 152 ESTONIA Saliva Collection Kit in CANCER SPIT TEST DEVICES MARKET, By Product Type, 2019-2028 (USD Million)

TABLE 153 ESTONIA CANCER SPIT TEST DEVICES MARKET, By Site of Collection, 2019-2028 (USD Million)

TABLE 154 ESTONIA CANCER SPIT TEST DEVICES MARKET, By Application, 2019-2028 (USD Million)

TABLE 155 ESTONIA CANCER SPIT TEST DEVICES MARKET, By Age Group, 2019-2028 (USD Million)

TABLE 156 ESTONIA CANCER SPIT TEST DEVICES MARKET, By Method of Collection, 2019-2028 (USD Million)

TABLE 157 ESTONIA CANCER SPIT TEST DEVICES MARKET, By End User, 2019-2028 (USD Million)

TABLE 158 ESTONIA CANCER SPIT TEST DEVICES MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 159 REST OF EUROPE CANCER SPIT TEST DEVICES MARKET, By Product TYPE, 2019-2028 (USD Million)

 

List of Figure

LIST OF FIGURES 

FIGURE 1 EUROPE CANCER SPIT TEST DEVICES MARKET : segmentation

FIGURE 2 EUROPE CANCER SPIT TEST DEVICES MARKET : data triangulation

FIGURE 3 EUROPE CANCER SPIT TEST DEVICES MARKET : DROC ANALYSIS

FIGURE 4 EUROPE CANCER SPIT TEST DEVICES MARKET: Europe vs REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE CANCER SPIT TEST DEVICES MARKET : COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE CANCER SPIT TEST DEVICES MARKET : INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE CANCER SPIT TEST DEVICES MARKET : DBMR MARKET POSITION GRID

FIGURE 8 EUROPE CANCER SPIT TEST DEVICES MARKET : MARKET APPLICATION COVERAGE GRID

FIGURE 9 EUROPE CANCER SPIT TEST DEVICES MARKET : vendor share analysis

FIGURE 10 EUROPE CANCER SPIT TEST DEVICES MARKET : SEGMENTATION

FIGURE 11 THE increasing prevalence of chronic diseases and rising healthcare expenditure are expected to drive THE EUROPE CANCER SPIT TEST DEVICES MARKET IN THE FORECAST PERIOD of 2021 to 2028

FIGURE 12 salvia Collection kit segment is expected to account for the largest share of the EUROPE CANCER SPIT TEST DEVICES MARKET in 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGEs OF Europe cancer Spit Test Devices Market

FIGURE 14 Estimated number of new cases in 2018, worldwide, both sexes, all ages

FIGURE 15 Estimated age-standardized incidence rates (World) in 2018, worldwide, both sexes, all ages

FIGURE 16 EUROPE CANCER SPIT TEST DEVICE MARKET: By product TYPE, 2020

FIGURE 17 EUROPE CANCER SPIT TEST DEVICE MARKET: By producT TYPE, 2021-2028 (USD million)

FIGURE 18 EUROPE CANCER SPIT TEST DEVICE MARKET: By product TYPE, CAGR (2021-2028)

FIGURE 19 EUROPE CANCER SPIT TEST DEVICE MARKET: By product TYPE, LIFELINE CURVE

FIGURE 20 Europe CANCER SPIT TEST DEVICE market: By SITE OF COLLECTION, 2020

FIGURE 21 Europe CANCER SPIT TEST DEVICE market: By SITE OF COLLECTION, 2021-2028 (USD million)

FIGURE 22 Europe CANCER SPIT TEST DEVICE market: By SITE OF COLLECTION, CAGR (2021-2028)

FIGURE 23 Europe CANCER SPIT TEST DEVICE market: By SITE OF COLLECTION, LIFELINE CURVE

FIGURE 24 Europe CANCER SPIT TEST DEVICE market: By APPLICATION, 2020

FIGURE 25 Europe CANCER SPIT TEST DEVICE market: By APPLICATION, 2021-2028 (USD million)

FIGURE 26 Europe CANCER SPIT TEST DEVICE market: By APPLICATION, CAGR (2021-2028)

FIGURE 27 Europe CANCER SPIT TEST DEVICE market: By APPLICATION, LIFELINE CURVE

FIGURE 28 EUROPE CANCER SPIT TEST DEVICE MARKET: By AGE GROUP, 2020

FIGURE 29 EUROPE CANCER SPIT TEST DEVICE MARKET: By AGE GROUP, 2021-2028 (USD million)

FIGURE 30 EUROPE CANCER SPIT TEST DEVICE MARKET: By AGE GROUP, CAGR (2021-2028)

FIGURE 31 EUROPE CANCER SPIT TEST DEVICE MARKET: By AGE GROUP, LIFELINE CURVE

FIGURE 32 Europe CANCER SPIT TEST DEVICE market: By METHOD OF COLLECTION, 2020

FIGURE 33 Europe CANCER SPIT TEST DEVICE market: By METHOD OF COLLECTION, 2021-2028 (USD million)

FIGURE 34 Europe CANCER SPIT TEST DEVICE market: By METHOD OF COLLECTION, CAGR (2021-2028)

FIGURE 35 Europe CANCER SPIT TEST DEVICE market: By METHOD OF COLLECTION, LIFELINE CURVE

FIGURE 36 Europe CANCER SPIT TEST DEVICE market: END USER, 2020

FIGURE 37 Europe CANCER SPIT TEST DEVICE market: END USER, 2021-2028 (USD million)

FIGURE 38 Europe CANCER SPIT TEST DEVICE market: END USER, CAGR (2021-2028)

FIGURE 39 Europe CANCER SPIT TEST DEVICE market: END USER, LIFELINE CURVE

FIGURE 40 Europe CANCER SPIT TEST DEVICE market: By DISTRIBUTION CHANNEL, 2020

FIGURE 41 Europe CANCER SPIT TEST DEVICE market: By DISTRIBUTION CHANNEL, 2021-2028 (USD million)

FIGURE 42 Europe CANCER SPIT TEST DEVICE market: By DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 43 Europe CANCER SPIT TEST DEVICE market: By DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 44 EUROPE CANCER SPIT TEST DEVICES MARKET: SNAPSHOT (2020)

FIGURE 45 EUROPE CANCER SPIT TEST DEVICES MARKET: BY COUNTRY (2020)

FIGURE 46 EUROPE CANCER SPIT TEST DEVICES MARKET: BY COUNTRY (2021 & 2028)

FIGURE 47 EUROPE CANCER SPIT TEST DEVICES MARKET: BY COUNTRY (2020 & 2028)

FIGURE 48 EUROPE CANCER SPIT TEST DEVICES MARKET: BY product TYPE (2021-2028)

FIGURE 49 EUROPE CANCER SPIT TEST DEVICES MARKET: COMPANY SHARE 2020 (%)

 

View Detailed Information Right Arrow

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.